Alligator Bioscience AB (ATORX)

Currency in SEK
0.0300
-0.0031(-9.37%)
Closed·

ATORX Earnings

Latest Release
May 05, 2026
EPS / Forecast
-- / --
Revenue / Forecast
98K / --
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2026/06--/----/------Free Sign Up
2026/030.000/--98.00K/------Free Sign Up
2025/12-0.660/--409.00K/------Free Sign Up
2025/09-0.340/--384.00K/------Free Sign Up
2025/06-0.080/--89.00K/------Free Sign Up
2025/03-1.11/--319.00K/------Free Sign Up
2024/12-73.10/--41.84M/------Free Sign Up
2024/09-2.14/--2.30M/------Free Sign Up
2024/06-1.42/-0.0607.90M/7.90M-2,266.67%0%Free Sign Up
2024/03-2.37/-0.1007.00M/7.00M-2,270%0%Free Sign Up

All numbers in SEK

Alligator Bioscience AB Earnings Call Summary for Q1/2026

  • Alligator Bioscience slashed annual operating costs from SEK 300M to SEK 100M, ending Q1 2026 with SEK 33M cash and runway through mid-Q3 2026.
  • Lead asset Mitazalimab showed 20% 30-month survival rate in Phase II; Phase III trial initiation planned for Q4 2026 with Q2 regulatory submissions.
  • Stock rose 4.69% post-earnings despite 95% annual decline; market cap stands at $15M with company exploring urgent financing options to continue operations.
  • Generated SEK 90M from TO 14 warrant exercises; potential HLX22 revenues projected from 2030, exploring expansion beyond pancreatic to biliary tract cancer.
Last Updated: 2026-05-05, 07:48 a/m
Read Full Transcript

FAQ

What Is Alligator Bioscience's Earnings Per Share (TTM)?

The Alligator Bioscience EPS (TTM) is -0.2580.

When Is The Next Alligator Bioscience Earnings Date?

Alligator Bioscience will release its next earnings report on Aug 27, 2026.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.